News

Category

Year

2025.11.17News Release

Maruho Announces Out-Licensing Agreement to China for Oral Penem Antibiotic (INN: Faropenem)

2025.11.04News Release

Maruho Enters a License Agreement with Nielsen BioSciences for the Treatment of Verruca Vulgaris (Common Warts) in Asia

2025.10.09News Release

Maruho Announces Exclusive Out-Licensing Agreement with Hyphens for In Vitro Diagnostic (Varicella-Zoster Virus Antigen Kit) in 10 ASEAN Countries

2025.09.30News Release

Maruho Announces Strategic minority Investment in Sibel Health

1